TapewireFind a company

person · Reporting owner

O'Hara Elaine

Disclosed activity across 1 company

Tapewire entity
62127
SEC CIK
0001968045

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
NOVAVAX INCNVAX · Entity 4632EVP, Chief Strategy OfficerMarch 02, 2026March 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

NOVAVAX INC

Report date March 02, 2026 · Filed March 09, 2026 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
2026 Non-statutory Stock Option NQSEC Table II · derivative / convertible security · Conversion / exercise price $10.11 · Expires 2036-03-02Direct177,500 Reported balance After 2026-03-02 transaction · row 1 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 1 · 2026-03-02 · Grant · Acquired 177,500 · Balance 177,500

F1: This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing.

F2: One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing.

F2: One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 03, 2026 Filed Mar 5, 2026 11:02 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionRestricted Stock Units · Derivative 56,334 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001104659-26-023720 · tm268076-2_4seq1.xml · derivative · entry 3

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,666

Underlying: Common Stock · 56,334 shares

Expires 2035-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 11:02 UTC NOVAVAX INC NVAX · Entity 4632 Tax withholdingCommon Stock 22,429 $9.49 $212,851.21
Disclosure

SEC source: 0001104659-26-023720 · tm268076-2_4seq1.xml · nonDerivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,642

F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 11:02 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionCommon Stock 56,334 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-023720 · tm268076-2_4seq1.xml · nonDerivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 Grant2026 Non-statutory Stock Option NQ · Derivative 177,500 $9.09 Strike: $9.09 $1,613,475.00
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · derivative · entry 8

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,500

Underlying: Common Stock · 177,500 shares

Expires 2036-03-02

F5 · derivative.exercise_date: One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 GrantRestricted Stock Units · Derivative 118,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · derivative · entry 7

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,000

Underlying: Common Stock · 118,000 shares

Expires 2036-03-02

F4 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date.

Read SEC document
March 02, 2026 Filed Mar 9, 2026 22:06 UTC Amendment NOVAVAX INC NVAX · Entity 4632 Grant2026 Non-statutory Stock Option NQ · Derivative 177,500 $0.00 Strike: $10.11 $0.00
Disclosure

SEC source: 0001104659-26-025361 · tm268290-1_4aseq1.xml · derivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,500

Underlying: Common Stock · 177,500 shares

Expires 2036-03-02

F1 · derivative.exercise_price: This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing.

F1 · price: This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing.

F2 · derivative.exercise_date: One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 01, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionRestricted Stock Units · Derivative 40,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · derivative · entry 6

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2034-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionRestricted Stock Units · Derivative 19,600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · derivative · entry 5

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,600 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 1, 2023, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 Tax withholdingCommon Stock 10,969 $10.14 $111,225.66
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · nonDerivative · entry 4

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,737

F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.

Read SEC document
March 01, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · nonDerivative · entry 3

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 Tax withholdingCommon Stock 5,375 $10.14 $54,502.50
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · nonDerivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,706

F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.

Read SEC document
March 01, 2026 Filed Mar 4, 2026 02:34 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionCommon Stock 19,600 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-023070 · tm267953-2_4seq1.xml · nonDerivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,081

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:02 UTC NOVAVAX INC NVAX · Entity 4632 Grant2025 Restricted Stock Units RSU · Derivative 169,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000303 · primary_01.xml · derivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,000

Underlying: Common Stock · 169,000 shares

Expires 2035-03-03

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:02 UTC NOVAVAX INC NVAX · Entity 4632 Grant2025 Non-statutory Stock Option NQ · Derivative 253,500 $7.87 Strike: $7.87 $1,995,045.00
Disclosure

SEC source: 0001593968-25-000303 · primary_01.xml · derivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,500

Underlying: Common Stock · 253,500 shares

Expires 2035-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:39 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionRestricted Stock Units · Derivative 40,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000285 · primary_01.xml · derivative · entry 6

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 40,000 shares

Expires 2034-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:39 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionRestricted Stock Units · Derivative 19,600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000285 · primary_01.xml · derivative · entry 5

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,600

Underlying: Common Stock · 19,600 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:39 UTC NOVAVAX INC NVAX · Entity 4632 Tax withholdingCommon Stock 10,969 $8.33 $91,371.77
Disclosure

SEC source: 0001593968-25-000285 · primary_01.xml · nonDerivative · entry 4

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,481

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:39 UTC NOVAVAX INC NVAX · Entity 4632 Tax withholdingCommon Stock 5,375 $8.33 $44,773.75
Disclosure

SEC source: 0001593968-25-000285 · primary_01.xml · nonDerivative · entry 3

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,450

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:39 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000285 · primary_01.xml · nonDerivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,825

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:39 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionCommon Stock 19,600 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000285 · primary_01.xml · nonDerivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,825

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:30 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionRestricted Stock Units · Derivative 19,600 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-031167 · tm248061-1_4seq1.xml · derivative · entry 3

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,200

Underlying: Common Stock · 19,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F2 · derivative.exercise_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:30 UTC NOVAVAX INC NVAX · Entity 4632 Tax withholdingCommon Stock 5,375 $5.39 $28,971.25
Disclosure

SEC source: 0001104659-24-031167 · tm248061-1_4seq1.xml · nonDerivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,225

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:30 UTC NOVAVAX INC NVAX · Entity 4632 Exercise / conversionCommon Stock 19,600 $5.39 $105,644.00
Disclosure

SEC source: 0001104659-24-031167 · tm248061-1_4seq1.xml · nonDerivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2024 Filed Mar 26, 2024 23:02 UTC NOVAVAX INC NVAX · Entity 4632 GrantRestricted Stock Units · Derivative 120,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-039166 · tm249879-5_4seq1.xml · derivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:02 UTC NOVAVAX INC NVAX · Entity 4632 GrantRestricted Stock Units · Derivative 58,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015688 · doc4.xml · derivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,800

Underlying: Common Stock · 58,800 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.

F3 · derivative.expiration_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:02 UTC NOVAVAX INC NVAX · Entity 4632 GrantStock Option (Right to buy) · Derivative 67,900 $0.00 Strike: $6.86 $0.00
Disclosure

SEC source: 0001209191-23-015688 · doc4.xml · derivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,900

Underlying: Common Stock · 67,900 shares

Expires 2033-03-01

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") 2023 Inducement Plan (the "Plan") will vest on the first anniversary of the March 1, 2023 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.